期刊文献+

脑功能显像剂^(99)Tc^m-Memantine的初步研究 被引量:1

Preliminary Study of ^(99)Tc^m-Memantine as an Brain Functional Imaging Agent
下载PDF
导出
摘要 用^(99)Tc^m标记N-[2-(N-(2-巯基乙基))氨基甲酰甲基]-N-(2-巯基乙基)-3,5-二甲基金刚烷胺基乙酰胺(N_2S_2-Memantine),生成了^(99)Tc^m(V)-Memantine。采用纸层析对此标记物进行质控并检测其体外稳定性。结果显示,湿法的标记率>90%,药盒化标记的标记物经乙酸乙酯萃取纯化后,放化纯度>95%,体外稳定性良好,有望成为一种新的脑功能显像剂。 N2S2-Memantine was labeled with 99Tcm using stannous fluoride as reducing agent, and the labeling conditions of 99 Tcm Memantine were optimized, and lyophilized kit of 99Tcm(V)-Memantine was also developed. The labeling efficiency was more than 90% by TLC and the kit radiochemical purity which was after extraction with ethyl acetate, was more than 95% . The stability was good in room temperature. 99Tcm( V )-Memantine would be a potential brain imaging agent which would need more research work.
出处 《同位素》 CAS 北大核心 2008年第4期215-219,共5页 Journal of Isotopes
基金 国家自然科学基金项目(30770602) 江苏省卫生厅重大项目(K200512)
关键词 99Tcm标记 美金刚胺 脑受体 显像剂 99 Tcm labeling memantine brain receptor imaging agent
  • 相关文献

参考文献14

  • 1WATKINS JC, JANE DE. The Glutamate Story [J]. Br J Pharmacol, 2006, 147 (Suppl 6): 100-108.
  • 2CARROLL RC, ZUKIN RS. NMDA-receptor Trafficking and Targeting: Implieations for Synaptic Transmission and Plastieity[J]. Trends Neurosci, 2002,25(11) :571-577.
  • 3KRYSTAL JH, D'SOUZA DC, PETRAKINS IL, et al. NMDA Agonists and Antagonists as Probes of Glutamatergic Dysfunction and Pharmacotherapies in Neuropsychiatric Disorders [J]. Harvard Rev Psych, 1999,7(3) : 125-143.
  • 4MELDRUM BS. Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology [J]. J Nutr ,2000,130(4S Suppl):1 007S-1 015S.
  • 5WATERHOUSE RN. Imaging the PCP Site of the NMDA Ion Channel[J]. Nucl Med Biol,2003, 30 (8) :869-878.
  • 6REYNOLDS IJ, ROTHERMUND K, RAJDEV S, et al. [^125I]Thienylpheneyclidine, a Novel Ligand for the NMDA Receptor[J]. Eur J Pharmacol,1992,226(1) :53-58.
  • 7BLIN J, DENIS A, YAMAGUCHI T,et al. PET Studies of [^18 F]methyl-MK-801, a Potential NMDA Receptor Complex Radioligand[J]. Neurosci Lett, 1991,121(1-2) :183-186.
  • 8AMETAMEY SM, SAMNICK S, LEENDERS KL, et al. Fluorine-18 Radiolabelling, Biodistribution Studies and Preliminary PET Evaluation of a New Memantine Derivative for Imaging the NMDA Receptor[J]. J Recept Signal Transduet Res, 1999, 19 (1-4) : 129-141.
  • 9KOIKCM, HONER M, KESSLERLJ, etal. Synthesis Vitro and in Vivo Evaluation of [^11C] Methyl-BIII277CL for Imaging the PCP-binding Site of the NMDA Receptor by Pet[J]. J Recept Signal Transduct Res, 2002,22(1-4) : 123-139.
  • 10ERLANDSSON K, BRESSAN RA, MULLIGAN RS, et al. Kinetic Modelling of [^123I]CNS 1261-a Potential SPET Tracer for the NMDA Receptor [J]. Nucl Med Biol, 2003,30(4) :441-454.

二级参考文献8

  • 1Kung M P,Eur J Nucl Med,1997年,24卷,4期,372页
  • 2Kung H F,Eur J Nucl Med,1996年,23卷,11期,1527页
  • 3Meltzer P C,J Med Chem,1993年,36卷,6期,855页
  • 4Dre s s er R.Seience.2000.11,289(5481) :869.
  • 5Muller WE, Mutsehler E, Riederer P. Pharmaeopsyehiatry. 1995,28(4):113-24.
  • 6Ditzler K. Arzneimittelforschung. 1991.41 (8) : 773 - 80.
  • 7Gortelmeyer B, Erbler H. Arzneimittelforschung. 1992,42(7) :904 - 13.
  • 8Yong Z, Xiaoyun X, Qibing M. Chinese, Journal of Pharmaccuricals,2003,34(5)213-214.

共引文献17

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部